Stem Cell Therapy in Autoimmune Diseases
Biomarkers, represented by genetically determined traits or biologic changes predictive of disease onset or outcome, are increasingly employed by academic and industrial investigators. They can identify unusually susceptible populations or individuals, facilitate prognosis, Currently, autoimmune conditions are treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade).
- Hematopoietic Stem Cell Therapy for Autoimmune Diseases
- Development of Hematopoietic Stem Cell Lines for Transplantation
- Gene Therapy and Stem Cell Approaches for the Treatment of Autoimmune Diseases
Related Conference of Stem Cell Therapy in Autoimmune Diseases
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Stem Cell Therapy in Autoimmune Diseases Conference Speakers
Recommended Sessions
- Autoimmune Diseases
- Cancer and Autoimmunity
- Complement in Autoimmunity
- Genetics and Epigenetics
- Infection and Autoimmunity
- Low Dose Naltrexone & Autoimmune Conditions
- Molecular Immunology
- New Cytokines and Anti-Cytokines
- Novel Therapeutic Targets
- Peptides and Autoimmune Diseases
- Prediction, Monitoring and Prevention
- Stem Cell Therapy in Autoimmune Diseases
- Therapy of Autoimmune Liver Disease
- Thyroid Autoimmunity
- Translational Immunology
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)